On January 2, 2024, Bioleaders Corporation closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,950 KRW | +0.05% |
|
+0.93% | -8.45% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,450 KRW | +0.31% | +0.16% | 187M | ||
1,950 KRW | +0.05% | +0.93% | 53.33M | ||
1st Jan change | Capi. | |
---|---|---|
-8.45% | 53.33M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- A142760 Stock
- News MOA Life Plus Co. Ltd.
- Bioleaders Corporation announced that it has received KRW 2 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.